Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 3/2018

01-04-2018 | Invited Review

Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines

Authors: U. W. Preuss, E. Gouzoulis-Mayfrank, U. Havemann-Reinecke, I. Schäfer, M. Beutel, E. Hoch, K. F. Mann

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 3/2018

Login to get access

Abstract

Alcohol use disorders (AUD) have a high comorbidity with mental disorders. Vice versa, alcohol consumption plays an important role in affective disorders, anxiety disorders, ADHD, schizophrenic psychosis, and other mental disorders. In developing the current interdisciplinary, evidence-based treatment guideline on screening, diagnostics, and treatment of AUD, available research on comorbid mental diseases in AUD has been compiled to generate recommendations for treatment. The guideline was prepared under the responsibility of the German Association for Psychiatry, Psychotherapy, and Psychosomatics (DGPPN) and the German Association for Addiction Research and Therapy (DG-Sucht). To meet the methodological criteria for the highest quality guidelines (“S3-criteria”) as defined by the Association of Scientific Medical Societies in Germany (AWMF), the following criteria were employed: (1) a systematic search, selection, and appraisal of the international literature; (2) a structured process to reach consensus; and (3) inclusion of all relevant representatives of future guideline users. After assessing and grading the available literature, the expert groups generated several recommendations for the screening, diagnosis, and treatment of comorbid mental disorders. These recommendations were subdivided into psycho-, pharmaco-, and combination therapies. These are the first guidelines ever to make specific treatment recommendations for comorbid mental diseases in AUD. The recommendations extend to different treatment approaches including diagnostics and settings to present available effective and state-of-the-art treatment approaches to clinicians. Hitherto, many clinical constellations have not been addressed in research. Therefore, recommendations for future research are specified.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoch E, Batra A, Mann K (2012) Das S3-Leitlinienprogramm für substanzbezogener Störungen. Sucht 2:14–25 Hoch E, Batra A, Mann K (2012) Das S3-Leitlinienprogramm für substanzbezogener Störungen. Sucht 2:14–25
2.
go back to reference Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ (2012) The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46:864–878CrossRefPubMed Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ (2012) The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46:864–878CrossRefPubMed
3.
go back to reference Hoch E, Petersen KU, Kopp I, Batra A, Mann K (2016) Methodik der S3-Leitlinien für alkohol- und tabakbezogene Störungen. Nervenarzt 87:6–12CrossRefPubMed Hoch E, Petersen KU, Kopp I, Batra A, Mann K (2016) Methodik der S3-Leitlinien für alkohol- und tabakbezogene Störungen. Nervenarzt 87:6–12CrossRefPubMed
4.
go back to reference Regier DA, Farmer ME, Rae DS (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511–2518CrossRefPubMed Regier DA, Farmer ME, Rae DS (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511–2518CrossRefPubMed
5.
go back to reference Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR (1995) Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 152:45–52CrossRefPubMed Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR (1995) Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 152:45–52CrossRefPubMed
6.
go back to reference Preuss UW (2008) Abhängigkeitserkrankungen und Psychosen: Erkenntnisse und Kontroversen in Vorbereitung auf neue Klassifikationssysteme. Die Psychiatrie 2:61–68 Preuss UW (2008) Abhängigkeitserkrankungen und Psychosen: Erkenntnisse und Kontroversen in Vorbereitung auf neue Klassifikationssysteme. Die Psychiatrie 2:61–68
7.
go back to reference Gouzoulis-Mayfrank E (2010) Komorbidität von Psychose und Sucht. Psychiatrie und Psychotherapie up2date 4: 81–95 Gouzoulis-Mayfrank E (2010) Komorbidität von Psychose und Sucht. Psychiatrie und Psychotherapie up2date 4: 81–95
8.
9.
go back to reference Bega S, Schaffer A, Goldstein B, Levitt A (2012) Differentiating between bipolar disorder types I and II: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Affect Disord 138:46–53CrossRefPubMed Bega S, Schaffer A, Goldstein B, Levitt A (2012) Differentiating between bipolar disorder types I and II: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Affect Disord 138:46–53CrossRefPubMed
10.
go back to reference Mann KF, Hoch E, Batra A (2016) AWMF-S3-Leitlinie “Screening, Diagnose und Behandlung alkoholbezogener Störungen”. Springer, HeidelbergCrossRef Mann KF, Hoch E, Batra A (2016) AWMF-S3-Leitlinie “Screening, Diagnose und Behandlung alkoholbezogener Störungen”. Springer, HeidelbergCrossRef
11.
go back to reference Preuss UW, Wong WMJ, Wurst FM (2012) Bipolar affektive Störungen und Alkoholkonsum-störungen: Komorbidität, Konsequenzen und Therapie. Spektrum Psychiatrie 2:47–51 Preuss UW, Wong WMJ, Wurst FM (2012) Bipolar affektive Störungen und Alkoholkonsum-störungen: Komorbidität, Konsequenzen und Therapie. Spektrum Psychiatrie 2:47–51
12.
go back to reference Cerullo MA, Strakowski SM (2007) The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abus Treat Prev Policy 2:29CrossRef Cerullo MA, Strakowski SM (2007) The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abus Treat Prev Policy 2:29CrossRef
13.
go back to reference Zimmermann P, Wittchen HU, Höfler M (2003) Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med 33:1211–1222CrossRefPubMed Zimmermann P, Wittchen HU, Höfler M (2003) Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med 33:1211–1222CrossRefPubMed
14.
go back to reference Galbraith T, Heimberg RG, Wang S, Schneier FR, Blanco C (2014) Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Anxiety Disord 28:57–66CrossRefPubMed Galbraith T, Heimberg RG, Wang S, Schneier FR, Blanco C (2014) Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Anxiety Disord 28:57–66CrossRefPubMed
15.
go back to reference Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52(12):1048–1060CrossRefPubMed Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52(12):1048–1060CrossRefPubMed
16.
go back to reference Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C (2012) The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 42:875–887CrossRefPubMed Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C (2012) The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 42:875–887CrossRefPubMed
17.
go back to reference Evren C, Sar V, Dalbudak E, Durkaya M, Cetin R, Evren B, Cakmak D, Ertem-Vehid H (2011) Lifetime PTSD and quality of life among alcohol-dependent men: impact of childhood emotional abuse and dissociation. Psychiatry Res 186:85–90CrossRefPubMed Evren C, Sar V, Dalbudak E, Durkaya M, Cetin R, Evren B, Cakmak D, Ertem-Vehid H (2011) Lifetime PTSD and quality of life among alcohol-dependent men: impact of childhood emotional abuse and dissociation. Psychiatry Res 186:85–90CrossRefPubMed
18.
go back to reference Johann M, Bobbe G, Putzhammer A, Wodarz N (2003) Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype. Alcohol Clin Exp Res 27:1527–1534CrossRefPubMed Johann M, Bobbe G, Putzhammer A, Wodarz N (2003) Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype. Alcohol Clin Exp Res 27:1527–1534CrossRefPubMed
19.
go back to reference Haber P, Lintzeris N, Proude E, Lopatko O (2009) Guidelines for the treatment of alcohol problems. Commonwealth of Australia Haber P, Lintzeris N, Proude E, Lopatko O (2009) Guidelines for the treatment of alcohol problems. Commonwealth of Australia
20.
go back to reference National Institute for Health and Clinical Excellence (NICE) (2011) Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115). London National Institute for Health and Clinical Excellence (NICE) (2011) Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115). London
21.
go back to reference DGPPN S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Schizophrenie (2006) Steinkopff Verlag, Darmstadt 43–109 DGPPN S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Schizophrenie (2006) Steinkopff Verlag, Darmstadt 43–109
22.
go back to reference Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI (2012) A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatr Scand 126:243–255CrossRefPubMed Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI (2012) A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatr Scand 126:243–255CrossRefPubMed
23.
go back to reference Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI (2011) Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 72:1144–1151CrossRefPubMed Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI (2011) Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 72:1144–1151CrossRefPubMed
24.
go back to reference Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O’Brien CP (2011) A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 167:668–675CrossRef Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O’Brien CP (2011) A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 167:668–675CrossRef
25.
go back to reference Hobbs J, Kushner MG, Lee SS (2011) Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. Am J Addict 20:319–329CrossRefPubMedPubMedCentral Hobbs J, Kushner MG, Lee SS (2011) Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. Am J Addict 20:319–329CrossRefPubMedPubMedCentral
26.
go back to reference Sannibale C, Teesson M, Creamer M, Sitharthan T, Bryant RA, Sutherland K, Taylor K, Bostock-Matusko D, Visser A, Peek-O’Leary M (2013) Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction 108:1397–1410CrossRefPubMed Sannibale C, Teesson M, Creamer M, Sitharthan T, Bryant RA, Sutherland K, Taylor K, Bostock-Matusko D, Visser A, Peek-O’Leary M (2013) Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction 108:1397–1410CrossRefPubMed
27.
go back to reference Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T (2010) The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA’s Women and Trauma Study. Drug Alcohol Depend 111:114–119CrossRefPubMedPubMedCentral Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T (2010) The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA’s Women and Trauma Study. Drug Alcohol Depend 111:114–119CrossRefPubMedPubMedCentral
28.
go back to reference Brady KT, Sonne SC (1995) The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56(Suppl 3):19–24PubMed Brady KT, Sonne SC (1995) The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56(Suppl 3):19–24PubMed
29.
go back to reference Flatten G, Gast U, Hofmann A, Knaevelsrud Ch, Lampe A, Liebermann P, Maercker A, Reddemann L, Wöller W (2011) Leitlinie Posttraumatische Belastungsstörung. Trauma und Gewalt 3:202–210 Flatten G, Gast U, Hofmann A, Knaevelsrud Ch, Lampe A, Liebermann P, Maercker A, Reddemann L, Wöller W (2011) Leitlinie Posttraumatische Belastungsstörung. Trauma und Gewalt 3:202–210
30.
go back to reference Emmerik van-Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA (2013) Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry 13:132CrossRefPubMedPubMedCentral Emmerik van-Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA (2013) Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry 13:132CrossRefPubMedPubMedCentral
31.
go back to reference Wilens TE, Adler LA, Weiss MD (2008) Atomoxetine ADHD/SUD Study Group Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 96:145–154CrossRefPubMed Wilens TE, Adler LA, Weiss MD (2008) Atomoxetine ADHD/SUD Study Group Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 96:145–154CrossRefPubMed
32.
go back to reference Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, Doreau HR, Hennen JA (2007) A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 164:100–107CrossRefPubMed Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, Doreau HR, Hennen JA (2007) A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 164:100–107CrossRefPubMed
33.
go back to reference Schadé A, Marquenie LA, van Balkom AJ, Koeter MW, de Beurs E, van Dyck R, van den Brink W (2007) Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. Eur Addict Res 13:109–115CrossRefPubMed Schadé A, Marquenie LA, van Balkom AJ, Koeter MW, de Beurs E, van Dyck R, van den Brink W (2007) Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. Eur Addict Res 13:109–115CrossRefPubMed
34.
go back to reference Thomas SE, Randall PK, Book SW, Randall CL (2008) A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res 32:77–84CrossRefPubMed Thomas SE, Randall PK, Book SW, Randall CL (2008) A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res 32:77–84CrossRefPubMed
35.
go back to reference Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Ralevski E, Rounsaville B (2006) Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry 60:777–783CrossRefPubMed Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Ralevski E, Rounsaville B (2006) Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry 60:777–783CrossRefPubMed
36.
go back to reference Moriyama TS, Polanczyk GV, Terzi FS, Faria KM, Rohde LA (2013) Psychopharmacology and psychotherapy for the treatment of adults with ADHD—a systematic review of available meta-analyses. CNS Spectr 6:1–11 Moriyama TS, Polanczyk GV, Terzi FS, Faria KM, Rohde LA (2013) Psychopharmacology and psychotherapy for the treatment of adults with ADHD—a systematic review of available meta-analyses. CNS Spectr 6:1–11
37.
go back to reference National Institute for Health and Clinical Excellence (NICE) (2008) Attention deficit hyperactivity disorder. Diagnostics and management of ADHD in children, young people and adults. Clinical Guidelines CG72. NICE, London National Institute for Health and Clinical Excellence (NICE) (2008) Attention deficit hyperactivity disorder. Diagnostics and management of ADHD in children, young people and adults. Clinical Guidelines CG72. NICE, London
39.
go back to reference Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M (2009) AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 62:1013–1020CrossRefPubMed Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M (2009) AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 62:1013–1020CrossRefPubMed
40.
go back to reference Gouzoulis-Mayfrank E (2007) Komorbidität Psychose und Sucht. Steinkopf Verlag, Würzburg Gouzoulis-Mayfrank E (2007) Komorbidität Psychose und Sucht. Steinkopf Verlag, Würzburg
41.
go back to reference Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62(1):37–45CrossRefPubMed Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62(1):37–45CrossRefPubMed
42.
go back to reference Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR (2009) A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 70(1):113–121CrossRefPubMed Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR (2009) A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 70(1):113–121CrossRefPubMed
43.
go back to reference Petrakis IL, Leslie D, Finney JW, Rosenheck R (2006) Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. Am J Addict 15(1):44–49CrossRefPubMed Petrakis IL, Leslie D, Finney JW, Rosenheck R (2006) Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. Am J Addict 15(1):44–49CrossRefPubMed
44.
go back to reference Brown ES, Garza M, Carmody TJ (2008) A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 69(5):701–705CrossRefPubMed Brown ES, Garza M, Carmody TJ (2008) A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 69(5):701–705CrossRefPubMed
45.
go back to reference Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, Rush A (2009) A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 33(11):1863–1869CrossRefPubMedPubMedCentral Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, Rush A (2009) A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 33(11):1863–1869CrossRefPubMedPubMedCentral
46.
go back to reference Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S (2010) A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 34(10):1822–1831CrossRefPubMed Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S (2010) A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 34(10):1822–1831CrossRefPubMed
47.
go back to reference Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT (2012) A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord 14(1):54–63CrossRefPubMed Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT (2012) A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord 14(1):54–63CrossRefPubMed
48.
go back to reference Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66:17–31CrossRefPubMed Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66:17–31CrossRefPubMed
49.
go back to reference Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61(8):807–816CrossRefPubMed Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61(8):807–816CrossRefPubMed
Metadata
Title
Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines
Authors
U. W. Preuss
E. Gouzoulis-Mayfrank
U. Havemann-Reinecke
I. Schäfer
M. Beutel
E. Hoch
K. F. Mann
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 3/2018
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-017-0801-2

Other articles of this Issue 3/2018

European Archives of Psychiatry and Clinical Neuroscience 3/2018 Go to the issue